Format

Send to:

Choose Destination
See comment in PubMed Commons below
Toxicol In Vitro. 2014 Feb;28(1):54-9. doi: 10.1016/j.tiv.2013.09.022. Epub 2013 Oct 2.

Way forward in case of a false positive in vitro genotoxicity result for a cosmetic substance?

Author information

  • 1Department of Toxicology, Center for Pharmaceutical Research, Vrije Universiteit Brussel, 1090 Brussels, Belgium. Electronic address: tatyana.yordanova.doktorova@vub.ac.be.

Abstract

The currently used regulatory in vitro mutagenicity/genotoxicity test battery has a high sensitivity for detecting genotoxicants, but it suffers from a large number of irrelevant positive results (i.e. low specificity) thereby imposing the need for additional follow-up by in vitro and/or in vivo genotoxicity tests. This could have a major impact on the cosmetic industry in Europe, seen the imposed animal testing and marketing bans on cosmetics and their ingredients. Afflicted, but safe substances could therefore be lost. Using the example of triclosan, a cosmetic preservative, we describe here the potential applicability of a human toxicogenomics-based in vitro assay as a potential mechanistically based follow-up test for positive in vitro genotoxicity results. Triclosan shows a positive in vitro chromosomal aberration test, but is negative during in vivo follow-up tests. Toxicogenomics analysis unequivocally shows that triclosan is identified as a compound acting through non-DNA reactive mechanisms. This proof-of-principle study illustrates the potential of genome-wide transcriptomics data in combination with in vitro experimentation as a possible weight-of-evidence follow-up approach for de-risking a positive outcome in a standard mutagenicity/genotoxicity battery. As such a substantial number of cosmetic compounds wrongly identified as genotoxicants could be saved for the future.

Copyright © 2013 Elsevier Ltd. All rights reserved.

KEYWORDS:

12-O-tetradecanoylphorbol-13-acetate; 2-nitrofluorene; 2NF; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test; 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; AFB1; Aflatoxin B1; BaP; CA; CND; CYCLO; Cosmetic ingredients; D-mannitol; GTX; HCA; K-Nearest Neighbours; KNN; LOO; Leave One Out; MAN; MN; MPH; MTT test; Mutagenicity/genotoxicity test battery; NC; NGTX; NIF; NNK; PCA; PIPB; SDF; SPB; TOL; TPA; TRI; Toxicogenomics-based in vitro models; Triclosan; WYE; Wy-14643; benzo(a)pyrene; chromosome aberration; clonidine; cyclophosphamide; diclofenac sodium; genotoxic; hierarchical clustering analysis; methapyrilene hydrochloride; micronucleus; nifedipine; non-carcinogen; non-genotoxic; phenobarbital sodium; piperonyl butoxide; principle component analysis; tolbutamide

PMID:
24095862
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk